POS1240 EFFICACY AND SAFETY OF ABATACEPT IN MYOSITIS ASSOCIATED INTERSTITIAL LUNG DISEASE
Rohit Aggarwal(University of Pittsburgh), Chester V. Oddis(University of Pittsburgh), Didem Saygın(University of Pittsburgh), Gary M. Hunninghake(Hubei University of Science and Technology), Sangmee Bae(University of California, Los Angeles), Aryeh Fischer(University of Colorado Denver), Tracy J. Doyle(Brigham and Women's Hospital), Jeremy Falk(UCLA Medical Center), Swamy R. Venuturupalli(Cedars-Sinai Medical Center), Galina Marder(Northwell Health), Paul F. Dellaripa(Brigham and Women's Hospital), Sonye K. Danoff(Johns Hopkins University), Yingsong Lin(Aichi Medical University), Caixia Kang(University of Pittsburgh), Siamak Moghadam‐Kia(University of Pittsburgh), Joyce Lee(Inserm), Dorothy Sullivan(University of Pittsburgh), Cheilonda Johnson(University of Pennsylvania), Dawn Koontz(University of Pittsburgh), Dana P. Ascherman(University of Pittsburgh)
Cited by 5
Related Papers
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
|American Journal of Respiratory and Critical Care Medicine|2018|4.1k
2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease‐modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis
|Arthritis Care & Research|2012|1.8k
Comorbidities and Risk of Mortality in Patients with Chronic Obstructive Pulmonary Disease
|American Journal of Respiratory and Critical Care Medicine|2012|1.3k
Diagnosis of Hypersensitivity Pneumonitis in Adults: An Official ATS/JRS/ALAT Clinical Practice Guideline
|American Journal of Respiratory and Critical Care Medicine|2020|1k
Serum Vitamin D Levels and Markers of Severity of Childhood Asthma in Costa Rica
|American Journal of Respiratory and Critical Care Medicine|2009|635